(Q43342861)

19 November 2017

Prevention of irinotecan (CPT-11)-induced diarrhea by oral alkalization combined with control of defecation in cancer patients (English)

1 reference

19 November 2017

0 references

1 reference

Y Takeda

1

1 reference

19 November 2017

K Kobayashi

2

1 reference

19 November 2017

Y Akiyama

3

1 reference

19 November 2017

T Soma

4

1 reference

19 November 2017

S Handa

5

1 reference

19 November 2017

S Kudoh

6

1 reference

19 November 2017

K Kudo

7

1 reference

19 November 2017

language of work or name

English

0 references

publication date

1 April 2001

1 reference

International Journal of Cancer

19 November 2017

1 reference

19 November 2017

92

1 reference

19 November 2017

2

1 reference

19 November 2017

269-275

1 reference

Randomised trial of irinotecan versus fluorouracil by continuous infusion after fluorouracil failure in patients with metastatic colorectal cancer.

19 November 2017

1 reference

https://api.crossref.org/works/10.1002%2F1097-0215%28200102%299999%3A9999%3C%3A%3AAID-IJC1179%3E3.0.CO%3B2-3

An early phase II study of CPT-11: a new derivative of camptothecin, for the treatment of leukemia and lymphoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0215%28200102%299999%3A9999%3C%3A%3AAID-IJC1179%3E3.0.CO%3B2-3

Characterisation and clinical management of CPT-11 (irinotecan)-induced adverse events: the European perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0215%28200102%299999%3A9999%3C%3A%3AAID-IJC1179%3E3.0.CO%3B2-3

High dose-intensity of irinotecan administered every 3 weeks in advanced cancer patients: a feasibility study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0215%28200102%299999%3A9999%3C%3A%3AAID-IJC1179%3E3.0.CO%3B2-3

A kinetic and mechanistic study of the hydrolysis of camptothecin and some analogues

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0215%28200102%299999%3A9999%3C%3A%3AAID-IJC1179%3E3.0.CO%3B2-3

Physiochemical and physiological mechanisms for the effects of food on drug absorption: the role of lipids and pH.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0215%28200102%299999%3A9999%3C%3A%3AAID-IJC1179%3E3.0.CO%3B2-3

Relationship between development of diarrhea and the concentration of SN-38, an active metabolite of CPT-11, in the intestine and the blood plasma of athymic mice following intraperitoneal administration of CPT-11.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0215%28200102%299999%3A9999%3C%3A%3AAID-IJC1179%3E3.0.CO%3B2-3

Irinotecan (CPT-11) and characteristic mucosal changes in the mouse ileum and cecum.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0215%28200102%299999%3A9999%3C%3A%3AAID-IJC1179%3E3.0.CO%3B2-3

Pharmacokinetic and pharmacodynamic evaluation of the topoisomerase inhibitor irinotecan in cancer patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0215%28200102%299999%3A9999%3C%3A%3AAID-IJC1179%3E3.0.CO%3B2-3

Ursodeoxycholate increases cytosolic calcium concentration and activates Cl- currents in a biliary cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0215%28200102%299999%3A9999%3C%3A%3AAID-IJC1179%3E3.0.CO%3B2-3

10.1002/1097-0215(200102)9999:9999<::AID-IJC1179>3.0.CO;2-3

21 January 2018

Identifiers

DOI

1 reference

19 November 2017

1 reference